BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24447564)

  • 1. [Clinicopathologic features of phyllodes tumors and their research progress].
    Xiao Y; Ruan QR
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):783-5. PubMed ID: 24447564
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent advances in molecular pathology of phyllodes tumor of breast].
    Niu Y
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):135-7. PubMed ID: 21426820
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preliminary analysis of chromosome abnormalities in breast mammary phyllodes tumour by comparative genomic hybridization (CGH)].
    Niu Y; Lü SH; Liu QJ; Wang XW; Chen Y; Ding XM
    Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):296-7. PubMed ID: 16777003
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast.
    Lim JC; Koh VC; Tan JS; Tan WJ; Thike AA; Tan PH
    Breast Cancer Res Treat; 2015 Feb; 150(1):19-29. PubMed ID: 25677742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast.
    Geyer FC; Burke KA; Piscuoglio S; Ng CKY; Papanastasiou AD; Marchiò C; Selenica P; Edelweiss M; Murray MP; Brogi E; Soslow RA; Rubin BP; Norton L; Reis-Filho JS; Weigelt B
    Mol Oncol; 2017 Aug; 11(8):913-926. PubMed ID: 28267263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phyllodes tumors of the breast segregate in two groups according to genetic criteria.
    Laé M; Vincent-Salomon A; Savignoni A; Huon I; Fréneaux P; Sigal-Zafrani B; Aurias A; Sastre-Garau X; Couturier J
    Mod Pathol; 2007 Apr; 20(4):435-44. PubMed ID: 17334353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal aberrations and genetic relations in benign, borderline and malignant phyllodes tumors of the breast: a comparative genomic hybridization study.
    Lv S; Niu Y; Wei L; Liu Q; Wang X; Chen Y
    Breast Cancer Res Treat; 2008 Dec; 112(3):411-8. PubMed ID: 18189161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An important subgroup of phyllodes tumors of the breast is characterized by rearrangements of chromosomes 1q and 10q.
    Polito P; Dal Cin P; Pauwels P; Christiaens M; Van den Berghe I; Moerman P; Vrints L; Van den Berghe H
    Oncol Rep; 1998; 5(5):1099-102. PubMed ID: 9683816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groups.
    Tan WJ; Lai JC; Thike AA; Lim JC; Tan SY; Koh VC; Lim TH; Bay BH; Tan MH; Tan PH
    Breast Cancer Res Treat; 2014 Jun; 145(3):635-45. PubMed ID: 24831776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic findings in phyllodes tumors of the breast: karyotypic complexity differentiates between malignant and benign tumors.
    Dietrich CU; Pandis N; Rizou H; Petersson C; Bardi G; Qvist H; Apostolikas N; Bøhler PJ; Andersen JA; Idvall I; Mitelman F; Heim S
    Hum Pathol; 1997 Dec; 28(12):1379-82. PubMed ID: 9416694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors: novel markers in biological classification.
    Chong LY; Cheok PY; Tan WJ; Thike AA; Allen G; Ang MK; Ooi AS; Tan P; Teh BT; Tan PH
    Breast Cancer Res Treat; 2012 Feb; 132(1):143-51. PubMed ID: 21574054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin expression in the epithelial components of mammary phyllodes tumors.
    Tsang JY; Mendoza P; Putti TC; Karim RZ; Scolyer RA; Lee CS; Pang AL; Tse GM
    Hum Pathol; 2012 Dec; 43(12):2117-23. PubMed ID: 22820000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 protein expression and gene mutation in phyllodes tumors of the breast.
    Gatalica Z; Finkelstein S; Lucio E; Tawfik O; Palazzo J; Hightower B; Eyzaguirre E
    Pathol Res Pract; 2001; 197(3):183-7. PubMed ID: 11314782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of anaphase-promoting complex7 in fibroadenomas and phyllodes tumors of breast.
    Kang Y; Kim JH; Lee TH; Kim TS; Jung WH; Chung HC; Park BW; Sheen SS; Han JH
    Hum Pathol; 2009 Jan; 40(1):98-107. PubMed ID: 18789487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-21 induces myofibroblast differentiation and promotes the malignant progression of breast phyllodes tumors.
    Gong C; Nie Y; Qu S; Liao JY; Cui X; Yao H; Zeng Y; Su F; Song E; Liu Q
    Cancer Res; 2014 Aug; 74(16):4341-52. PubMed ID: 24980553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic findings in phyllodes tumor and fibroadenomas of the breast.
    Barbosa ML; Ribeiro EM; Silva GF; Maciel ME; Lima RS; Cavalli LR; Cavalli IJ
    Cancer Genet Cytogenet; 2004 Oct; 154(2):156-9. PubMed ID: 15474152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral breast tumors, malignant phyllodes tumor and invasive lobular carcinoma in a 46,XX/46,XY mosaic female with family history of breast cancer.
    Kasami M; Yoshida M; Isogaki J; Ogawa H; Shinmura K; Endo Y; Kiyokawa E; Naito Y; Arai T; Kimura T; Inoue R; Sugimura H
    Pathol Int; 1997; 47(2-3):147-54. PubMed ID: 9088032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
    Jia C; Mei F; Zheng J; You JF; Liu JY
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic and cytogenetic observations on a case of giant fibroadenoma.
    Olinici CD; Simu G
    Neoplasma; 1970; 17(6):663-5. PubMed ID: 4323588
    [No Abstract]   [Full Text] [Related]  

  • 20. Complex karyotype in a low grade phyllodes tumor of the breast.
    Ladesich J; Damjanov I; Persons D; Jewell W; Arthur T; Rogana J; Davoren B
    Cancer Genet Cytogenet; 2002 Jan; 132(2):149-51. PubMed ID: 11850078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.